Skip to main content
Premium Trial:

Request an Annual Quote

Crosslinks Licenses Tibco's Software

NEW YORK (GenomeWeb News) – Dutch software services company Crosslinks has licensed Tibco Software's Spotfire analytics platform, and will distribute it across Europe, Tibco said today.

Rotterdam-based Crosslinks was founded in 2006 as a spin off from Erasmus University Medical Center.

"When Crosslinks was launched, our aim was always to provide the Spotfire enterprise analytics platform to the academic world," Ronald Nanninga, Crosslinks CEO, said in a statement.

"Under the terms of the new license agreement signed with TIBCO at the start of the year, we have started to provide licensing agreements to academic researchers in the Netherlands and the rest of Europe who are active in the field of life sciences — especially genomics and proteomics," Nanninga said.

Financial terms of the agreement were not released.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.